Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Mayo Clinic Graduate School of Biomedical Sciences, Virology and Gene Therapy Track, Mayo Clinic, Rochester, Minnesota 55905.
J Biol Chem. 2020 Feb 28;295(9):2771-2786. doi: 10.1074/jbc.REV119.009961. Epub 2020 Jan 16.
Research in the last decade has uncovered many new paramyxoviruses, airborne agents that cause epidemic diseases in animals including humans. Most paramyxoviruses enter epithelial cells of the airway using sialic acid as a receptor and cause only mild disease. However, others cross the epithelial barrier and cause more severe disease. For some of these viruses, the host receptors have been identified, and the mechanisms of cell entry have been elucidated. The tetrameric attachment proteins of paramyxoviruses have vastly different binding affinities for their cognate receptors, which they contact through different binding surfaces. Nevertheless, all input signals are converted to the same output: conformational changes that trigger refolding of trimeric fusion proteins and membrane fusion. Experiments with selectively receptor-blinded viruses inoculated into their natural hosts have provided insights into tropism, identifying the cells and tissues that support growth and revealing the mechanisms of pathogenesis. These analyses also shed light on diabolically elegant mechanisms used by morbilliviruses, including the measles virus, to promote massive amplification within the host, followed by efficient aerosolization and rapid spread through host populations. In another paradigm of receptor-facilitated severe disease, henipaviruses, including Nipah and Hendra viruses, use different members of one protein family to cause zoonoses. Specific properties of different paramyxoviruses, like neurotoxicity and immunosuppression, are now understood in the light of receptor specificity. We propose that research on the specific receptors for several newly identified members of the family that may not bind sialic acid is needed to anticipate their zoonotic potential and to generate effective vaccines and antiviral compounds.
在过去的十年中,研究发现了许多新的副黏病毒,这些空气传播的病原体可导致动物(包括人类)爆发流行病。大多数副黏病毒使用唾液酸作为受体进入气道上皮细胞,只会引起轻微疾病。然而,其他病毒会穿过上皮屏障,引起更严重的疾病。对于其中一些病毒,宿主受体已经被鉴定出来,细胞进入的机制也已经阐明。副黏病毒的四聚体附着蛋白与它们的同源受体具有截然不同的结合亲和力,它们通过不同的结合表面接触受体。然而,所有输入信号都被转化为相同的输出:触发三聚体融合蛋白和膜融合重新折叠的构象变化。用选择性受体盲病毒接种其自然宿主的实验提供了对嗜性的深入了解,确定了支持生长的细胞和组织,并揭示了发病机制的机制。这些分析还揭示了麻疹病毒等麻疹病毒等恶魔般巧妙的机制,这些机制可促进宿主内的大量扩增,然后通过宿主种群有效气溶胶化和快速传播。在另一个受体促进严重疾病的范例中,亨德拉病毒和尼帕病毒等亨尼帕病毒使用同一蛋白家族的不同成员引起人畜共患病。不同副黏病毒的特定特性,如神经毒性和免疫抑制,现在根据受体特异性来理解。我们提出,需要研究几种新鉴定的家族成员的特定受体,这些成员可能不与唾液酸结合,以预测它们的人畜共患潜力,并产生有效的疫苗和抗病毒化合物。